The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Machilskaya O.V.

Cardiology clinic of the I.M. Sechenov First Moscow State Medical University, Russian Ministry of Health, Moscow, Russia

The factors determining adherence to treatment in arterial hypertension patients (literature review)

Authors:

Machilskaya O.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(3): 55‑65

DOI: 10.17116/kardio20169355-65

Views: 11700

Downloaded: 464

Download PDF (RU)
Contact the author
Table of contents

THE FACTORS DETERMINING ADHERENCE TO TREATMENT IN ARTERIAL HYPERTENSION PATIENTS (LITERATURE REVIEW)
THE FACTORS DETERMINING ADHERENCE TO TREATMENT IN ARTERIAL HYPERTENSION PATIENTS (LITERATURE REVIEW)

To cite this article:

Machilskaya OV. The factors determining adherence to treatment in arterial hypertension patients (literature review). Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(3):55‑65. (In Russ.)
https://doi.org/10.17116/kardio20169355-65

Подписка 2025-2 (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Arte­rial hype­rtension in patients — mili­tary fighting participants. Russian Journal of Preventive Medi­cine. 2024;(5):128-132
Maintenance immu­nosuppressive therapy for Crohn’s disease: patient adhe­rence and its impact on treatment effi­cacy. Case report. Russian Journal of Evidence-Based Gastroenterology. 2024;(2):90-96
Adhe­rence to treatment in the mana­gement of patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):26-32
Multifocal athe­rosclerosis: epidemiology and treatment adhe­rence. Russian Journal of Preventive Medi­cine. 2024;(8):107-113
Fore­nsic characteristic of sudden death cases in subjects with meta­bolic syndrome. Fore­nsic Medi­cal Expe­rtise. 2024;(4):54-57
Fore­nsic asse­ssment of meteorological conditions as risk factors of sudden death from arte­rial hype­rtension. Fore­nsic Medi­cal Expe­rtise. 2024;(4):65-68
Method of manual-physical correction in the treatment of hype­rtensive disease and normalization of psychoneurological status in patients with dege­nerative-dystrophic processes of the musculoskeletal system. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(4):16-22
Impo­rtance of pare­ntal compliance in postoperative reha­bilitation of children with glaucoma. Russian Annals of Ophthalmology. 2024;(4):12-16
«Selfish brain» theory: modern concept and practical use. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):66-73
Predictors of Enga­gement and Active participation of Patients with Unco­ntrolled Hype­rtension in the Tele­health Surveillance Program. Russian Journal of Preventive Medi­cine. 2024;(12):37-43

Keywords:

adherence to treatment
compliance
hypertension

Authors:

Machilskaya O.V.

Cardiology clinic of the I.M. Sechenov First Moscow State Medical University, Russian Ministry of Health, Moscow, Russia

List of references:

  1. Аgeev F.T., Mareev V.YU., Patrusheva I.F. Do we choose correctly the hypotensive drug in routine outpatient practice and how to fix this situation? (According to a study of Moscow Cardiac Dispensary and multicenter studies FLAG and FAGOT). Serdtse. 2003;2(4):185-189.(in Russian)
  2. Аmlaev K.R., Makhov Z.D., Kojchueva S.M., Kojchuev А.А. Methods to determine the level of adherence to treatment and reasons for its decrease. Vestnik Stavropol'skogo gosudarstvennogo universiteta. 2012;3:225-229.(in Russian)
  3. Аrabidze G.G., Belousov YU.B., Karpov YU.А. Аrterial'naya gipertoniya. Spravochnoe rukovodstvo po diagnostike i lecheniyu. M. 1999. (in Russian)
  4. Baksheev V.I., Kolomoets N.M., Tursunova G.F. Clinical efficacy of hypertensive patients' school at the outpatient stage. Terapevticheskij arkhiv. 2005;77(11):49-55.(in Russian)
  5. Bryukhanov А.N., Luk'yanenko P.T., Petrova А.S. "Hypertension school" in polyclinic. Vrach. 1998;10:19-20.
  6. Gurevich K.G. Compliance of patients intaking antihypertensive therapy. Kachestvennaya klinicheskaya praktika. 2003;4:53- 58.(in Russian)
  7. Diagnostika i lechenie arterial'noj gipertenzii. Rekomendatsii Rossijskogo meditsinskogo obshhestva po arterial'noj gipertonii i Vserossijskogo nauchnogo obshhestva kardiologov (4-j peresmotr). Sistemnye gipertenzii. 2010;3:5-26.(in Russian)
  8. Ipatov А.I., Аrabidze G.G., Tebloev K.I., i dr. Clinical efficacy and safety of Noliprel in patients with hypertension. Kardiologiya. 2002;42(9):49-52.(in Russian)
  9. Kemp R, Devid А, KHejvord P. Komplaens-terapiya. Per. S angl. Obzor sovremennoj psikhiatrii. 2000;5:91-101. (in Russian)
  10. Kobalava ZH.D., Villeval'de S.V., Isikova KH.V. Efficiency of structured educational programs and the rational use of Prestarium in relation to increase of adherence and motivation to antihypertensive therapy. PRISMA study results. Klinicheskaya farmakologiya i terapiya. 2011;4:15-21.(in Russian)
  11. Kobalava ZH.D., Kotovskaya YU.V., Starostina E.G., i dr ot imeni issledovatelej АRGUS-2. Adherence of patients to antihypertensive therapy and the obstacles to its improvement: results of Russian scientific-practical program ARGUS-2. Terapevticheskij arkhiv. 2008;3:76-82.(in Russian)
  12. Kobalava ZH.D., Starostina E.G., Kotovskaya YU.V., Villival'de S.V., Baranova E.I., Bogachev R.S., Volkova N.I., Drozdetskij S.I., Kislyak O.А., Koziolova N.А., Kolina I.G., Krasnova YU.N., Lopatin YU.M., Maksimenko V.V., Nedogoda S.V., Tarlovskaya E.I., Tyukalova L.I., KHokhlov R.А., Frejdlina M.А. ot imeni issledovatelej АRGUS-2. Adherence of patients to antihypertensive therapy and the obstacles to its improvement: results of Russian scientific-practical program ARGUS-2. Terapevticheskij arkhiv. 2008;80:3:76-82.(in Russian)
  13. Konradi А.O. Hypertension: how to stop the epidemic. Kardiovaskulyarnaya terapiya i profilaktika. 2004;4:12-19.(in Russian)
  14. Konradi А.O. Znachenie priverzhennosti k terapii v lechenii kardiologicheskikh zabolevanij. Consilium medicum. Spravochnik poliklinicheskogo vracha. 2007;4:6:8-12.(in Russian)
  15. Konradi А.O., Polunicheva E.V.Insufficient adherence to treatment of hypertension: Causes and Correction. Аrterial'naya gipertenziya. 2004;10:3:137-143.(in Russian)
  16. Kotovskaya YU.V., Villeval'de S.V., Tigaj ZH.G., Kobalava ZH.D., ot imeni vrachej-uchastnikov programmy KONSTАNTА. The adherence, motivation and awareness of hypertensive patients in treatment with combination of perindopril and amlodipine A (CONSTANTA findings). Terapevticheskij arkhiv. 2015;87:2: 64-69.(in Russian)
  17. Lazebnik L.B., Podkopaev D.V., Komissarenko I.А., Mikheeva O.M.. How to improve the compliance of hypertensive patients to treatment? Аrterial'naya gipertenziya. 2011;17:3:240-245.(in Russian)
  18. Martynov А.А., Spiridonova E.V., Butareva M.M. Increase of patients' adherence to treatment and rehabilitation programs and the factors influencing this compliance. Vestnik dermatologii i venerologii. 2012;1:21-27.(in Russian)
  19. Moiseev V.S., Kobalava ZH.D. АRGUS: arterial'naya gipertoniya u lits starshikh vozrastnykh grupp. M.: MIА. 2002.(in Russian)
  20. Morozova T.E., YUdina I.YU. Sovremennaya strategiya uluchsheniya priverzhennosti lecheniyu bol'nykh arterial'noj gipertenziej: fiksirovannye kombinatsii lekarstvennykh sredstv. Consilium medicum. 2010;22:1:22-28.(in Russian)
  21. Neznanov N.G., Vid V.D. Problema komplaensa v klinicheskoj psikhiatrii [The problem of compliance in clinical psychiatry]. Psikhiatriya i psikhofarmakoterpiya. 2004;6(4):159-162.(in Russian)
  22. Nefedov I.V., Blintsova E.V., Аdzhienko V.L., Frolov M.YU. Adherence to antihypertensive treatment (compliance) in patients with cardiovascular diseases. Lekarstvennyj vestnik. 2012;6:6(46):24-30.(in Russian)
  23. Oganov R.G., Pogosova G.V., SHal'nova S.А., Deev А.D. Depressive disorders in general medical practice according to a COMPASS study:cardiologist's view. Kardiologiya. 2005;8:38-44.(in Russian)
  24. Belousov YU.B., Leonova M.V.,Belousov D.YU., Vyalkov А.I., i dr.Osnovy klinicheskoj farmakologii i ratsional'noj
  25. Otsenka faktorov komplaentnosti psikhicheskikh bol'nykh I vliyanie na nikh komorbidnykh rasstrojstv. Metodicheskie rekomendatsii. Sankt-Peterburg. 2012.(in Russian)
  26. Oshhepkova E.V., Isaeva L.G. Low adherence to treatment in hypertensive patients: the approaches to improve it. Аtmosfera. Kardiologiya: ZHurnal dlya praktikuyushhikh vrachej. 2003;3:33-36.(in Russian)
  27. Oshhepkova E.V., TSagareishvili E.V., Rogoza А.N. Self-monitoring of blood pressure increases patients' adherence to treatment of hypertension (monitoring for 1 year). Sistemnye gipertenzii. 2004;6(2):2-4.(in Russian)
  28. Pogosova G.V., Koltunov I.E., Melik-Ogandzhanyan G.YU., Sokolova O.YU. Compliance with treatment for cardiovascular diseases: the problem of doctors and patients // Kardiovaskulyarnaya terapiya i profilaktika. 2009;4:98-102.(in Russian)
  29. Fofanova T.V., Orlova YA.А. Patrusheva I.F., i dr. Felodipine in ambulatory practice: what can influence the efficacy of the treatment and compliance with therapy in patients with hypertension. RMZH. 2009;17(5):392-396.(in Russian)
  30. KHokhlov А.L., Lisenkova L.А., Rakov А.А. An analysis of the factors determining compliance with antihypertensive therapy. Kachestvennaya klinicheskaya praktika. 2003;4:59-66.(in Russian)
  31. CHazov E.I. Depressive symptoms worsens the prognosis of patients with hypertension and coronary heart disease: first results of a prospective stage of Russian multicenter study COORDINATE. Kardiologiya. 2007;10:24-30.(in Russian)
  32. CHazov E.I., Oganov R.G., Pogosova G.V., i dr. Depressive symptoms worsens the prognosis of patients with hypertension and coronary heart disease: first results of a prospective stage of Russian multicenter study COORDINATE. Kardiologiya. 2007;47:10:24-30.(in Russian)
  33. CHazova I.E. Combined treatment of hypertension. Аrterial'naya gipertenziya. 2001;2:22-26.(in Russian)
  34. CHukaeva I.I. Compliance and possibilities of full-dose combined antihypertensive drugs. Аrterial'naya gipertenziya. 2012;18:1:46-51.(in Russian)
  35. SHal'nova S.А. Epidemiology of arterial hypertension in Russia: patient's portrait. Аrterial'naya gipertenziya. 2008;2:56-62. (in Russian)
  36. SHal'nova S.А., Balanova YU.А., Konstantinov V.V., i dr. Arterial hypertension: prevalence, awareness, intake of antihypertensive drugs and the effectiveness of treatment among the population of the Russian Federation. Rossijskij kardiologicheskij zhurnal. 2006;4:45-50.(in Russian)
  37. SHal'nova S.А, Deev А.D., Vikhireva O.V. Hypertension from the point of view of ambulatory patients. The first results of the Garant trial. Kardiovaskulyarnaya terapiya I profilaktika. 2007;5:30-33.(in Russian)
  38. EHjdel'man S.E. Pharmacoepidemiology of hypertension in the Petrograd district of St. Petersburg. Аrterial'naya gipertenziya. 2003;9:12-13. (in Russian)
  39. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281- 1357.
  40. Alam MG, Barri YM. Systolic blood pressure is the main etiology for poorly controlled hypertension. Am J Hypertens. 2003;16:140-143.
  41. Alfonso LM, Agramonte MS, Vea HDB. Frecuencia de cumplimiento del tratamiento en pacientes hipertensos. Rev Cubana Gen Inregr. 2003;19(2):aproximadamente 4.
  42. Aranda P, Ruilope LM, Calvo C, et al. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: results of a Spanish study. Am J Hypertens. 2004;17:139-145.
  43. Arpa MR, Agomuob DI, Odia OJ. Drug compliance among hypertensive in Port Harcourt, Nigeria. Niger J Med. 2005;14:55-57.
  44. Bangalore S, Kamalakkanan G, Parkar S, Messerli FH. Fixeddose combinations improve medication compliance: a metaanalysis. Am J Med. 2007;120:713-719.
  45. Barron JJ, Daniel G, Makin C, et al. Treatment modifications and resourse use for fixed-dose vs separate-agent antihypertensive regimens. Drug Benefit Trends. 2008;20:226-247.
  46. Benson J, Britten N. Keep taking the tablets. BMJ 2003; 326: 1314-7; Fletcher A. Quality of life in the management of hypertension. Clin Exp Hypertens. 1999;21:961-972.
  47. Black HR, Elliott WJ, Grandits G, et al. Results of the Controlled ONset Verapamil Investigation of Cardiovascular Endpoints (СONVINCE) trial by geographical region. J Hypertens. 2005;23:1099-1106.
  48. Bosworth HB, Granger BB, Mendys P, Burkholder R, Czajkowski SM, et al. Medication adherence: a call for action. Am Heart J. 2011;162:412-424.
  49. Brixner DI, Jackson KC, Sheng X, et al. Assessment of adherence, persistence, and costs among valsartan and hydrochlorthiazide retrospective cohorts in free- and fixed-dose combinations. Curr Med Res Opin. 2008;24:2597-2607.
  50. Byrd ChE. Understanding adherence to the typical anti-hypertensive treatment regimen: An expanded self-regulation theory based prediction model: a dissertation for the degree of doctor of philosophy. Gainesville. 2004;190.
  51. Сaetano P, Lam J, Morgan S. Toward a standart definition and мeasurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther. 2006;28:1411-1424.
  52. Compliance with antihypertensive telmisartan therapy. Available at: http://wwwClinicalTrials. Gov identifier NCT00470886 on 27.03.2011.
  53. Chapman А. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165:1147-1152.
  54. Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165:1147-1152.
  55. Cramer JA. Partial medication compliance: the enigma in poor medical outcomes. American Journal of Managed Care. 1995;1:45-52.
  56. Сramer J, Roy A, Вurrell A, et al. Medication compliance and persistence: terminology and definitions. Value health. 2008;11:44-47.
  57. Degli Esposti L, Degli Esposti E, Valpiani G, et al. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther. 2002;24:1347-1357.
  58. Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care. 2000;9(Suppl 9):2-6.
  59. Dickson M, Plauschinat CA. Сompliance with antihypertensive therapy in the elderly: a comprasion of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy. Am J Cardiovasc Drugs. 2008;8:45-50.
  60. Egan BM. Fixed-dose combinations and hypertension control in community-based practices: application of the <> principle. Hypertension. 2009;53(4):598-599.
  61. Fahey T, Schroeder K, Ebrahim S. Educational and organizational interventions used to improve the management of hypertension in primary care: a systematic rewiew. Br J Gen Pract. 2005;55:875-882.
  62. Filippi A, Sabatini A, Badioli L. Effects of an automated electronic reminder in changing the antiplateled drug- prescribing behavior among Italian general practinioners in diabetic patients: an intervention trial. Diabetes Care. 2003 May;26(5):1497-1500.
  63. Fodor GJ, Kotrec M, Bacskai K, et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-Europian study. J Hypertens. 2005;23:1261-1266.
  64. Friedman R.H. J Med System. 1998;22(2):95-101.
  65. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9(4Pt 1):285-292.
  66. Gerbino PP, Shoheiber O. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. Am J Health Syst Pharm. 2007;64:1279-1283.
  67. Gossec L, Tubach F, Dougados M, Ravaud P. Reporting of adherence to medication in recent randomized controlled trails of 6 chronic diseases: a systematic literature rewiew. Am J Med Sci. 2007;334:248-254.
  68. Gupta AK, Arshad S, Poulter NR. Compliance safety and effectiveness of fixed-dose combinations of antihypertensive agents: a metaanalysis. Hypertension. 2010;55:2:399-407.
  69. Hagstrom B, Mattsson B, Rost IM, Gunnarsson RK. What happened to the prescriptions? A single, short, standardized telephone call may increase compliance. Fam Pract. 2004;21(1):46-50.
  70. Hamilton GA. Measuring adherence in a hypertension clinical trial. J Manag Care Pharm. 9(5):424-429.
  71. Hasford J, Schroder-Bernhardi D, Rottenkolber M, et al. Persistence with antihypertensive treatments: results of a 3-year followup cohort study. Eur J Clin Pharmacol. 2007;63:1055-1061.
  72. Haynes BR, Sackett DL, Gibson ES, et al. Improvement of medical compliance in uncontrolled hypertension. Lancet. 1976;i:1265- 1268.
  73. Hess G. Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy. PT. 2008;33:652-666.
  74. Hill M, Houston N. Adherence to antihypertensive therapy. 2007;131:390-392.
  75. Hosie J, Wiklund I, Sung JСY, Nichol MB, Venturini F, et al. 1998.
  76. Ishisaka DY, Jukes T, Romanelli RJ, Wong KS, Schiro TA. Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. J Am Soc Hypertens. 2012;6(3):201-209.
  77. Jin J, Sklar GE, Oh VMS, et al. Factors affecting therapeutic compliance: A rewiew from the patient`s perspective. Ther Clin Risk Manag. 2008;4(1);269-286.
  78. Jokisalo E, Enlund H, Halonen P, et al. Factors related to poor control of blood pressure with antihypertensive drug therapy. Blood Press. 2003;12(1):49-55.
  79. Jones JK, Gorkin L, Lian JF, et al. Discontinuation of and changes in treatmen tafter start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ. 1995;311:293-295.
  80. Jonsson B, Hansson L, Stalhammar NO. Health economics in the Hypertension Optimal Treatment (HOT) study: costs and costoeffectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension. J Intern Med. 2003;253:472-480.
  81. Kim MT, Han HR, Hill MN, et al. Depression, substanceuse, adherence behaviors, and blood pressure in urban hypertensive blackmen. Ann Behav Med. 2003;26(1):24-31.
  82. Labdenpra TS, Wright CC, Kyngas HA. Development of a scale to assess the compliance of hypertensive patients. Int J Nurs Stud. 2003 Sep;40(7):677-684.
  83. Lau DS, Lee G, Wong CC, et al. Characterization of systemic hypertension in the San Francisco Chinese community. Am J Cardiol. 2005;96:570-573.
  84. Lee JK, Grace KA, Taylor AJ. Effect of pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trail. JAMA. 2006;296(21):2563-2571.
  85. Lehane E, McCarty G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int Nurs Stud. 2007;44:1468-1477.
  86. Lewis D, Robinsh Videoon J, Wilkinson E. Factors involved in deciding to start preventive treatment: qualitative study of clinician`s and lay people attitudes. BMJ. 2003;327:841.
  87. Liu L, Zhang Y, Liu G, et al. The Felodipine EVEnt Reduction (FEVER) study: A randomized longoterm placebo controlled trail in Chinese hypertensive patients. J Hypertens. 2005;23:2157-2172.
  88. Lowry K, Dudley T, Oddone E, Bosworth H. International and uninternational non- adherence to antihypertensive medication. Ann Pharmacother. 2005;39:1198-1203.
  89. Malesker MA, Hilleman DE. Сomprasion of amlodipine/valsartan fixed-dose combination therapy and conventional therapy. Manag Care. 2010;19:36-42.
  90. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598-1605.
  91. McKenny JM, Munroe WP, Wright JTJr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol. 1992;32(3):277-283.
  92. McKinstry B. Do patients wish to be involved in decision making in the consultation A cross sectional survey with video vignettes. BMJ. 2000;321:867-871.
  93. Miklowitz D, George Е, Richards J, et al. A randomised stydy of family-focused psychoeducation and pharmaecotherapy in the outpatient managment of bipolar disorder. Arch Gen Psychiatry. 2003;60:904-912.
  94. Monane M, et al. Am J Hypertens. 1997;10(7):697-704.
  95. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
  96. Nikolaus T, Kruse W, Bach M, Specht- Leible, et al. Elderly patients problems with medication. An in hospital and follow-up study. Europ J оf Clin Pharm. 1996;49:255-259.
  97. Ohene Buabeng K, Matowe L, Plange-Rhule J. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharm Sci. 2004;7(3):350-352.
  98. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
  99. Payne KS, Esmonde-White S. Curr Hupertens Rep. 2000;2:515- 524. 
  100. Perreault S, Lamarre D, Blais L, et al. Persistence with treatment in newly treated middle-aged patients with essential hypertension. Ann Pharmacother. 2005;39(9):1401-1408.
  101. Port K, Palm K, Viigimaa M. Self-reported compliance of patients receiving antihypertensive treatment: use of a telemonitoring home care system. J Telemed Telecare. 2003;9(Suppl. 1):S65-S66.
  102. Pruijum MT, Maillard MP, Burnier M. Приверженность пациентов лечению и выбор антигипертензивной терапии: фокус на лекардипин. Service of Nephrology and Hypertension, Department of Medicine, University Hospital, Lausanne, Switzerland. Vasc Heal Risk Managment. 2008;4(6):1159-1166.
  103. Raji MA, Kuo YF, Salazar JA, et al. Ethnic differences in antihypertensive medication use in the elderly. Ann Pharmacother. 2004;38:209-214. 
  104. Redwood H. Hypertension, society, and public policy. Eur Heart J 2007; 9 (Suppl B):B13-B18. 
  105. Riera AR. Hipertens aoarterial: conceitospraticose terapeutica. SaoPaulo: Atheneu. 2000.
  106. Ryan TJ, Anderson JL. Practice guidelines: American College of Cardiology and American Heart Association. New York: Elsevier Science Inc. 1996.
  107. Salas M, In`t Veld BA, van der Linden PD, et al. Impaired cognitive function and compliance with antihypertensive drugs in elderly: the Rotterdam Study. Clin Pharmacol Ther. 2001;70:561-566.
  108. Schoberberger R, Janda M, Pescosta W, Sonneck G. The COMpliance Praxis Survey (COMPASS): a multidimensional instrument to monitor compliance for patients on antihypertensive medication. J Hum Hypertens. 2002;16:779-787. 
  109. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure – lowering medication in ambulatory care? Systematic review of randomized controlled trails. Arch Intern Med. 2004;164:722-732. 
  110. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. The Cochrane Database of Systematic Reviews. The Cochrane Collaboration: John Wiley and Sons, Ltd. 2006. Issue 4. 
  111. Sewitch MJ, Leffondre K, Dobkin PL. Clustering patients according to health perceptions: relationhips to psychosocial characteristics and medication nonadherence. J Psychosom Res. 2004;56:323-332. 
  112. Shaya FT, Du D, Gbarayor CM, et al. Predictors of compliance with antihypertensive therapy in a high-risk Medicaid population. J Natl Med Assoc. 2009;101:34-39. 
  113. Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazeprilHCl versus comparable component-based therapy. Congest Heart Fail. 2003;9:324-332. 
  114. Vander Stichele. Measuremeent of patient compliance and the interpretation of randomized trials. Eur J Clin Pharmacol. 1991;41:27-35. 
  115. Vaur L, et al. Am J Hypertens. 1999;12(4 Pt1):374-380.
  116. Vrijens B, Goethrbeur E. Comparing compliance patterns between randomized treatments. Controlled clinical trials. 1997;18:187-203. 
  117. Vrijens B, Vincze G, Kristano P, et al. Adherence to prescribed antihypertensive drug treatments: a longitudinal study of electronically dosing histories. BMJ. 2008;336: 1114-1117.
  118. Waeber В. Treatment strategy to control blood pressure optimally in hypertensive patients. Blood pressure. 2001;10:62-73. 
  119. Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients? J Cardiovasc Pharmacol. 2000;36(suppl. 3):S23-S26. 
  120. Wang L. Physician-related barriers to hypertension management. Med Princ Pract. 2004;13(5):282-285.
  121. Wang PS, Bohn RL, Knight E, et al. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intеrn Med. 2002;17(7):504-511.
  122. Wei J, Hollin I, Kachnowski S. A rewiew of the use of mobile phone text messaging in clinical and healthy behavior interventions. J Telemed Telecare. 2011;17:41-48.
  123. Wilson-Davis K. Study design and the use of statistics in drug use research. In: McGavock H. (ed). Handbook of Use Research Methodology. 1sted. Newcastle: The United Kingdom Drug Utilization Research Group. 2000;36-55. 
  124. Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens. 2004;22:1849-1855.
  125. World Health Organisation (2003): Adherence to long-term therapies, evidence for action. Geneva: (Электрон. ресурс). Режим доступа: http: //www.who. int2.
  126. World Health Organization: Adherence to long-term therapies: evidence for action. 2010. http://www. who. int/chp/knowledge/publications/adherence_report/en/index.html.
  127. Zeng F, Patel B, Andrews L, et al. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens. Curr Med Res Opin. 2010;26(12):2877-2887.
  128. http://korrespondent. net/tech/192424.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.